Division of Gastroenterology and Hepatology, Digestive Health Center, University of Virginia, Charlottesville, Virginia 22908, USA.
Ann Hepatol. 2009 Oct-Dec;8(4):346-52.
Epidemiological studies indicate that nonalcoholic steatohepatitis (NASH) is a common cause of cirrhosis described as 'cryptogenic'. To address this from a histological perspective and to examine the significance of residual histological findings as an indication of prior NASH, we looked back at biopsies in patients who presented with cirrhosis without sufficient histological features to diagnose NASH but who had prior histologically confirmed non-cirrhotic NASH.
Seven patients were identified with biopsy pairs showing non-specific (cryptogenic) cirrhosis in the latest specimen and a prior biopsy showing non-cirrhotic NASH. Using an expanded NASH-CRN system scored blindly by light microscopy, we compared the early and late biopsies to each other and to a cohort of 13 patients with cirrhosis due to hepatitis C without co-existing metabolic syndrome.
Macrosteatosis, although uniformly present in the non-cirrhotic NASH specimens, declined in the late stage cirrhotic NASH specimens and was not useful in the distinction of late cirrhotic NASH from cirrhotic viral hepatitis. However, the presence of ballooned cells, Mallory-Denk bodies, and megamitochondria and the absence of apoptotic bodies were significantly different in late stage cirrhotic NASH compared to cirrhosis due to hepatitis C.
Histologically advanced NASH presenting as non-specific or cryptogenic cirrhosis has residual changes which are consistent with prior steatohepatitis but which differ from cirrhosis due to hepatitis C. These results provide histological support for the more established epidemiological associations of NASH with cryptogenic cirrhosis and for criteria used in several proposed classifications of cryptogenic cirrhosis.
流行病学研究表明,非酒精性脂肪性肝炎(NASH)是一种常见的“隐匿性”肝硬化病因。为了从组织学角度解决这个问题,并研究残留组织学发现作为先前 NASH 指示的意义,我们回顾了一些患者的活检,这些患者因肝硬化就诊,但组织学特征不足以诊断 NASH,但先前的组织学检查已证实存在非肝硬化性 NASH。
确定了 7 名患者,他们的最新活检标本显示为非特异性(隐匿性)肝硬化,而先前的活检标本显示为非肝硬化性 NASH。我们使用扩展的 NASH-CRN 系统,通过光学显微镜进行盲法评分,将早期和晚期活检相互比较,并与 13 名因丙型肝炎导致的肝硬化而无并存代谢综合征的患者进行比较。
尽管非肝硬化性 NASH 标本中普遍存在大泡性脂肪变性,但在晚期肝硬化性 NASH 标本中减少,并且在晚期肝硬化性 NASH 与丙型肝炎导致的肝硬化的鉴别中没有用处。然而,晚期肝硬化性 NASH 与丙型肝炎导致的肝硬化相比,气球样细胞、Mallory-Denk 体、巨线粒体的存在和凋亡小体的缺失存在显著差异。
表现为非特异性或隐匿性肝硬化的组织学晚期 NASH 仍有残留变化,这些变化与先前的肝炎一致,但与丙型肝炎导致的肝硬化不同。这些结果为 NASH 与隐匿性肝硬化的更广泛的流行病学关联以及几个隐匿性肝硬化分类标准中使用的标准提供了组织学支持。